Bardavon Health Innovations Secures $90 Million In Series C Funding To Advance True Msk Technology Platform Beyond Workers’ Compensation Care
Oct 20, 2021•about 4 years ago
Amount Raised
$90 Million
Round Type
series c
Description
Bardavon Health Innovations, a Workers’ Compensation and musculoskeletal (MSK) health company, announced a Series C funding of $90 million led by investor Matrix Capital Management, a public and private investment firm, joined by WestCap, a growth equity firm.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech